Misunderstanding the Genome: A (Polite) Rant
By Jonathan Gitlin,
ArsTechnica
| 07. 08. 2015
A recent Ars feature story about genetic screening generated quite a lively debate in the discussion thread. However, it also underlined just how many misconceptions people have when it comes to genetics. Public perception hasn't been helped by scientists overhyping their findings or by inaccurate portrayals in the media (GATTACA, anyone?). So today, I'm going to try to clear some common confusions.
Before moving recently to Ars full time, I spent six years working in the policy office of the National Human Genome Research Institute, the part of the National Institutes of Health responsible for the Human Genome Project (along with the UK's Wellcome Trust). The job gave me a front row seat to the challenge of explaining a horribly complex topic, one where common assumptions are often counterfactual.
Maria Delany's Ars article does a great job laying out how screening at-risk individuals for mutations in a pair of genes—BRCA1 and BRCA2—can spare people from developing cancer. Delany also explains why there isn't unanimity among clinicians about rolling out BRCA testing at the population level. At first glance, such...
Related Articles
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...